Ruubix Inc is categorized under Commercial Biotechnical Research in Los Angeles, CA and active since 2010.
Ruubix Inc was established in 2010, and today employs 1 to 4, earning Unknown per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 5417114 by the NAICS.
If you are seeking more information, feel free to contact Ayub Khattak, Chief Executive Officer at the company’s single location by writing to 1100 Glendon Avenue # 1741, Los Angeles, California CA 90024 or by phoning (310) 689-7530. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ruubix Inc |
| Contact Person: | Ayub Khattak, Chief Executive Officer |
| Address: | 1100 Glendon Avenue # 1741, Los Angeles, California 90024 |
| Phone Number: | (310) 689-7530 |
| Website Address: | ruubix.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5417114 |
| Share This Business: |
Ruubix Inc was started in 2010 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Ayub Khattak, Chief Executive Officer for inquiries that concern Ruubix Inc by calling the company number (310) 689-7530, as your correspondence is most welcome. Additionally, the physical location of the single location of Ruubix Inc can be found at the coordinates 34.060715,-118.444477 as well as the street address 1100 Glendon Avenue # 1741 in Los Angeles, California 90024.
For its online presence, you may visit Ruubix Inc’s website at ruubix.com and engage with its social media outlets through on Twitter and on Facebook.